The PET Radiotracer Translation and Resource Center (PET-RTRC)
Project Number5P41EB025815-07
Former Number5P41EB025815-05
Contact PI/Project LeaderGROPLER, ROBERT J.
Awardee OrganizationWASHINGTON UNIVERSITY
Description
Abstract Text
Overall Project Summary
In this renewal application of our National Center for Biomedical Imaging and Bioengineering (NCBIB), the PET
Radiotracer and Translation Center (PET-RTRC), our objective is to further fortify the Center as a national
resource that leverages the expertise at Washington University and the Mallinckrodt Institute of Radiology in
PET radiotracer design, development, production, training and dissemination. In collaboration with research
groups throughout the country and in Europe who are studying molecular and cellular processes of inflammation
in disease, we will further enhance the development and dissemination of novel PET radiotracers needed to
transform biomedical research and advance human health. In the process we will strengthen the foundation for
propelling the PET-RTRC forward and sustaining its long term operation. To fulfill our objective we will address
the following Specific Aims:
Aim 1: In responding to the scientific needs of the Collaborative Projects (CPs), the three Technological
Research & Development Projects (TR&Ds 1-3) will build upon their successful innovations during the current
funding cycle to develop radiotracers that target different components of inflammation, their dynamic variation,
and consequences such as inflammasome activation (TR&D 1: sphingosine-1-phosphate receptor-2),
monocyte/macrophage trafficking (TR&D 2: chemokine C receptor 2/CD163) and the induction of mitochondrial
stress (TR&D 3: mitochondrial reactive oxygen species). Aim 2: Given the importance of the CPs as technology
drivers, we will further enhance the “push-pull” interaction between the individual TR&Ds and their respective
CPs by including strategies that enhance cross-site communication, more robust training opportunities,
optimized image analysis and data management and facilitated sharing of intellectual property. Aim 3: The
Technology Training and Dissemination Core expands its success in the current grant cycle to offer robust
training and dissemination opportunities. In the training component, all Center workshops and seminars will be
presented in a hybrid onsite/remote mode, individualized training will be offered via proctored “how to” videos
on key topics and additional outreach initiatives will be implemented that are geared towards interactions with
other P41 Centers, internal WU training grants/programs and traditionally underserved universities. New
innovations in our dissemination efforts will increase the capabilities of our Service Projects for both pre-clinical
and human studies. The Administration Core will continue to provide the managerial oversight necessary for
the efficient operation of the PET-RTRC so that it meets its scientific, training and dissemination objectives.
Successful completion of the proposed renewal application will further propel the PET-RTRC as a national
resource to facilitate research that will increase our understanding of the molecular basis of disease, thus
providing the framework for novel diagnostic and therapeutic paradigms leading to improved human health.
Public Health Relevance Statement
Overall Project Narrative
PET Radiotracer and Translation Center (PET-RTRC) is a national resource that leverages the expertise of
research groups throughout the country and in Europe to enhance the development and dissemination of novel
PET radiotracers needed to transform biomedical research and advance human health.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Advisory CommitteesAgreementAreaBiologicalBiologyBiomedical EngineeringBiomedical ResearchCOVID-19 pandemicCell PhysiologyChemistryClinicalCollaborationsCommunicationCommunitiesCountryDataDevelopmentDiseaseEducational workshopEuropeEvaluationFortificationFoundationsFundingGrantHealthHumanHybridsImageImage AnalysisIndividualInflammasomeInflammationInflammation ProcessInfrastructureIntellectual PropertyInvestigational New Drug ApplicationLearningMacrophageMitochondriaMolecularNational Institute of Biomedical Imaging and BioengineeringPerformancePositron-Emission TomographyProcessProductionProtocols documentationPublished CommentRadiology SpecialtyReactive Oxygen SpeciesResearchResource InformaticsResourcesScheduleServicesSiteSphingosine-1-Phosphate ReceptorStandardizationStressTechnologyTrainingTraining ProgramsTranslationsUniversitiesVariantVisionVisitWashingtonbiomedical imagingdata managementdesigngamma-Chemokineshuman diseaseimaging facilitiesimprovedinnovationlecturesmembermonocytenovelnovel diagnosticsnovel therapeuticsoperationoutreachpre-clinicalprecision medicinepreclinical imagingpreclinical studyprogramsquantitative imagingradiotracerreceptorsuccesstechnology research and developmenttechnology trainingtraffickingtraining opportunity
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
068552207
UEI
L6NFUM28LQM5
Project Start Date
01-September-2018
Project End Date
31-July-2028
Budget Start Date
01-August-2024
Budget End Date
31-July-2025
Project Funding Information for 2024
Total Funding
$1,310,650
Direct Costs
$850,000
Indirect Costs
$460,650
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$1,310,650
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P41EB025815-07
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P41EB025815-07
Patents
No Patents information available for 5P41EB025815-07
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P41EB025815-07
Clinical Studies
No Clinical Studies information available for 5P41EB025815-07
News and More
Related News Releases
No news release information available for 5P41EB025815-07
History
No Historical information available for 5P41EB025815-07
Similar Projects
No Similar Projects information available for 5P41EB025815-07